CIBC Private Wealth Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $7.26M | Sell |
59,110
-1,201
| -2% | -$146K | 0.01% | 388 |
|
|
2025
Q3 | $6.69M | Sell |
60,311
-6,926
| -10% | -$787K | 0.01% | 389 |
|
|
2025
Q2 | $7.45M | Buy |
67,237
+21,768
| +48% | +$2.32M | 0.01% | 380 |
|
|
2025
Q1 | $4.69M | Buy |
45,469
+264
| +0.6% | +$27.2K | 0.01% | 407 |
|
|
2024
Q4 | $4.03M | Buy |
45,205
+2,983
| +7% | +$269K | 0.01% | 461 |
|
|
2024
Q3 | $3.54M | Sell |
42,222
-2,008
| -5% | -$153K | 0.01% | 482 |
|
|
2024
Q2 | $2.99M | Sell |
44,230
-1,030
| -2% | -$68.7K | 0.01% | 480 |
|
|
2024
Q1 | $3.3M | Sell |
45,260
-10,698
| -19% | -$823K | 0.01% | 463 |
|
|
2023
Q4 | $4.53M | Sell |
55,958
-1,472
| -3% | -$115K | 0.01% | 401 |
|
|
2023
Q3 | $4.3M | Sell |
57,430
-8,891
| -13% | -$684K | 0.01% | 400 |
|
|
2023
Q2 | $5.11M | Sell |
66,321
-4,540
| -6% | -$362K | 0.01% | 398 |
|
|
2023
Q1 | $7.31M | Sell |
70,861
-4,005
| -5% | -$332K | 0.02% | 347 |
|
|
2022
Q4 | $4.5M | Buy |
74,866
+4,753
| +7% | +$376K | 0.02% | 338 |
|
|
2022
Q3 | $4.33M | Buy |
70,113
+963
| +1% | +$60.7K | 0.01% | 385 |
|
|
2022
Q2 | $4.27M | Buy |
69,150
+3,063
| +5% | +$190K | 0.01% | 388 |
|
|
2022
Q1 | $3.93M | Sell |
66,087
-1,950
| -3% | -$125K | 0.01% | 425 |
|
|
2021
Q4 | $4.94M | Sell |
68,037
-447
| -0.7% | -$30.8K | 0.01% | 408 |
|
|
2021
Q3 | $4.78M | Sell |
68,484
-425
| -0.6% | -$29.9K | 0.01% | 398 |
|
|
2021
Q2 | $4.75M | Buy |
68,909
+508
| +0.7% | +$33.9K | 0.01% | 409 |
|
|
2021
Q1 | $4.42M | Sell |
68,401
-6,679
| -9% | -$431K | 0.01% | 412 |
|
|
2020
Q4 | $4.38M | Sell |
75,080
-196,114
| -72% | -$11.8M | 0.01% | 395 |
|
|
2020
Q3 | $17.1M | Buy |
271,194
+34,105
| +14% | +$2.37M | 0.05% | 224 |
|
|
2020
Q2 | $18.2M | Sell |
237,089
-14,724
| -6% | -$1.13M | 0.09% | 153 |
|
|
2020
Q1 | $18.8M | Buy |
251,813
+8,042
| +3% | +$556K | 0.08% | 177 |
|
|
2019
Q4 | $15.8M | Sell |
243,771
-22,207
| -8% | -$1.45M | 0.05% | 230 |
|
|
2019
Q3 | $16.9M | Buy |
265,978
+15,643
| +6% | +$1.02M | 0.06% | 222 |
|
|
2019
Q2 | $16.9M | Buy |
250,335
+19,165
| +8% | +$1.26M | 0.06% | 232 |
|
|
2019
Q1 | $15M | Sell |
231,170
-9,894
| -4% | -$658K | 0.06% | 235 |
|
|
2018
Q4 | $15.1M | Buy |
241,064
+24,827
| +11% | +$1.74M | 0.07% | 219 |
|
|
2018
Q3 | $16.7M | Buy |
216,237
+11,822
| +6% | +$893K | 0.06% | 231 |
|
|
2018
Q2 | $14.5M | Buy |
204,415
+18,894
| +10% | +$1.33M | 0.06% | 242 |
|
|
2018
Q1 | $14M | Buy |
185,521
+15,939
| +9% | +$1.27M | 0.06% | 247 |
|
|
2017
Q4 | $12.2M | Buy |
169,582
+20,797
| +14% | +$1.58M | 0.05% | 272 |
|
|
2017
Q3 | $12.1M | Buy |
148,785
+70,236
| +89% | +$5.37M | 0.06% | 261 |
|
|
2017
Q2 | $5.56M | Buy |
78,549
+21,372
| +37% | +$1.42M | 0.03% | 277 |
|
|
2017
Q1 | $3.88M | Sell |
57,177
-7,849
| -12% | -$552K | 0.02% | 301 |
|
|
2016
Q4 | $4.66M | Sell |
65,026
-118,627
| -65% | -$8.82M | 0.03% | 292 |
|
|
2016
Q3 | $14.5M | Sell |
183,653
-40,588
| -18% | -$3.3M | 0.1% | 160 |
|
|
2016
Q2 | $18.7M | Buy |
224,241
+691
| +0.3% | +$61.3K | 0.14% | 140 |
|
|
2016
Q1 | $20.5M | Buy |
223,550
+41,023
| +22% | +$3.7M | 0.16% | 129 |
|
|
2015
Q4 | $18.5M | Buy |
182,527
+52,554
| +40% | +$5.47M | 0.14% | 142 |
|
|
2015
Q3 | $12.8M | Buy |
129,973
+49,468
| +61% | +$5.49M | 0.11% | 165 |
|
|
2015
Q2 | $9.43M | Buy |
80,505
+17,973
| +29% | +$1.96M | 0.07% | 220 |
|
|
2015
Q1 | $6.14M | Buy |
62,532
+1,252
| +2% | +$127K | 0.05% | 267 |
|
|
2014
Q4 | $5.78M | Sell |
61,280
-330
| -0.5% | -$34.1K | 0.04% | 266 |
|
|
2014
Q3 | $6.56M | Sell |
61,610
-2,195
| -3% | -$215K | 0.05% | 250 |
|
|
2014
Q2 | $5.29M | Buy |
63,805
+4,015
| +7% | +$313K | 0.04% | 266 |
|
|
2014
Q1 | $4.42M | Buy |
+59,790
| New | +$4.69M | 0.04% | 287 |
|
Other funds holding GILD
CIBC Private Wealth Group's GILD Position: Q4 2025 in Review
CIBC Private Wealth Group reduced its Gilead Sciences (GILD) stake by 2% in Q4 2025, selling an estimated $146K and leaving 59,110 shares worth $7.26M. The position accounts for 0.01% of the portfolio, ranked #388.
CIBC Private Wealth Group first reported a position in GILD in Q1 2014 and has held it in 48 quarters since. The position peaked at $20.5M in Q1 2016. 2,216 funds tracked by Wall St. Rank hold GILD as of Q4 2025.
- CIBC Private Wealth Group held 59,110 shares of Gilead Sciences worth $7.26M as of Q4 2025.
- CIBC Private Wealth Group sold 1,201 Gilead Sciences shares in Q4 2025, an estimated $146K.
- Gilead Sciences made up 0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #388 holding.
- CIBC Private Wealth Group first reported a position in Gilead Sciences in Q1 2014 and has held it in 48 quarters since.
- CIBC Private Wealth Group's Gilead Sciences position peaked at $20.5M in Q1 2016.
- 2,216 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.
Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.